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ABSTRACT: Successful pathogen detection is crucial for public health as the threat of infectious disease is dramatically increasing 
globally due to bacteria developing resistance to many anti-microbial drugs. The increase in bacterial infections has led to urgent de-
mands for simpler, faster and more reliable detection methods to be developed, so that the most appropriate therapy can be provided. 
Surface enhanced Raman scattering (SERS) is an analytical technique which has gained a great deal of interest for biosensing due to its 
sensitivity, selectivity and multiplexing capabilities. A new bionanosensor has been developed for the isolation and detection of multiple 
bacterial pathogens via magnetic separation and SERS. This novel assay format involves using lectin functionalised magnetic nanopar-
ticles for capture and isolation of bacteria from the sample matrix followed by specifically detecting bacterial pathogens using SERS 
active nanoparticles functionalised with antibodies which are strain specific. TKHUHIRUHWKHVDPSOHLVFDSWXUHGXVLQJDµPDJQHWLFSOXJ¶
and interrogated with a laser allowing simple and fast optical detection. Three bacterial pathogens ± Escherichia coli, Salmonella typhi-
murium and methicillin-resistant Staphylococcus aureus ± were successfully isolated and detected, with the lowest concentration for each 
of the strains detected at just 101 colony forming units per mL (CFU/mL). In addition to single pathogen detection, a mixture of all 
three bacterial strains were isolated and identified within the same sample matrix using SERS with the triplex detection also being 
confirmed using principal component analysis. Herein, we demonstrate that this multiplexed bionanosensor is capable of providing 
rapid and sensitive discrimination of bacterial pathogens both individually, and within a multiplex system, offering opportunities for 
future point of care devices and advancements in bio-medical applications. 
Successful pathogen detection is a critical step in ensuring 
food safety and the health of the general public.1 Over the years, 
there have been many threats to human health from bacterial 
infections such as Escherichia coli and methicillin-resistant Staphy-
lococcus aureus (MRSA) leading to a surge of ingenious strategies 
for isolating and detecting microorganisms in connection with 
food safety, medical diagnostics, water quality, and bioterror-
ism.2,3 Commonly, pathogenic bacteria are detected using con-
ventional methods which rely on lengthy and laborious microbi-
ological, morphological or biochemical identification. Generally 
these methods fall within three categories; culture-colony count-
ing methods, polymerase chain reaction (PCR) and immunology 
based techniques such as enzyme-linked immunosorbent assays.1 
These methods can provide sensitive, qualitative and quantita-
tive data on the microorganisms being analysed, however, they 
can also be expensive, require specialised equipment with spe-
cially trained staff and/or be time consuming as they often re-
quire an initial enrichment step.4,5 In order to overcome these 
deficiencies, biosensor technology has grown exponentially in 
the last 25 years as it has the capability of providing sensitive and 
reliable results which equate to conventional methods but with 
much shorter analysis times and the added benefit of analysis be-
ing deployed directly on site. 4,6,7,8  
Surface enhanced Raman scattering (SERS) is an ultra-sensi-
tive and selective analytical technique that can be used to detect 
target molecules attached to or in close-proximity to the surface 
of noble metal nanoparticles, commonly silver and gold are 
used.9  The enhancements observed are orders of magnitude 
greater than those reported for conventional Raman scattering, 
however, the enhancements vary widely depending on analyte 
and substrate.10,11 Additional enhancements, up to 1014 can be 
achieved by tuning the laser frequency with an electronic transi-
tion within the analyte hence using a chromophore to give rise 
to the phenomenon known as surface enhanced resonance Ra-
man scattering (SERRS). The main advantage of Raman based 
techniques are their ability to provide sharp, molecularly specific 
spectra making it possible to easily discriminate between individ-
ual components in a sample mixture, therefore making it an ideal 
technique for the detection of multiple analytes.12,13 
To date, there have been many SERS bionanosensors devel-
oped which focus on bacterial pathogen detection.2,3,14-19 Zhang 
et al. used aptamer functionalised gold nanoparticles to detect 
Salmonella typhimurium and Staphylococcus aureus in pork at con-
centrations of 15 and 35 CFU/mL respectively.20 Pazos-Perez et 
al. approached the bacterial detection E\GHVLJQLQJD µPLFURRU
JDQLVPRSWLFDOGHWHFWLRQV\VWHP¶FRQVLVWLQJRIDPLFURIOXLGLFGH
vice and micropump which flushed the bacterial sample through 
the device to a Raman microscope where they analysed the sam-
ple using a 785 nm laser. They reported the detection of  multiple 
bacterial strains at concentrations of 106 CFU/mL.21 
 Moreover, there has been an influx in papers recently which 
use a µPDJQHWLFVHSDUDWLRQ¶DSSURDFK7KLV LQYROYHVXVLQJPDJ
netic nanoparticles plus a magnet to capture and isolate bacteria 
from a complex matrix volume, giving rise to increased SERS sig-
nal.1,22-26 Najafi et al. detected E. coli in apple juice at 102 
CFU/mL;23 while Guven et al. reported detection limits of 8 
CFU/mL in water within 70 min.22 Furthermore, Wang et al. 
reported that S. typh and S. aureus could be detected simultane-
ously in spiked spinach and peanut butter at concentrations of 
103 CFU/mL, when SERS was combined with a magnetic sepa-
ration step.1 The bionanosensors which have been developed are 
starting to address the issue of detecting multiple bacterial path-
ogens simultaneously with 2-3 targets being identified in a sample 
matrix. They produce reproducible results in comparable times 
however, they lack the sensitivity, efficiency and ease of our ap-
proach. Many of them, require complex separation steps or re-
quire dropping the sample onto a surface before analysis, result-
ing in extra handling steps and increased preparation times. Es-
sentially our approach is a sandwich SERS assay (Figure 1) in 
which we combine SERS active silver nanoparticles functional-
ised with bacteria specific recognition molecules (antibodies) 
with lectin functionalised magnetic nanoparticles enabling the 
capture and isolation of bacteria through magnetic separation. It 
is the use of lectin functionalised magnetic nanoparticles, which 
makes this separation step novel and efficient in capturing and 
isolating bacteria from a sample matrix.  
Lectins are carbohydrate binding proteins that bind specifi-
cally to sugars. They have been reported to specifically recognise 
and bind to carbohydrate constituents expressed on the surface 
of bacteria.27,28 Concanvalin A (Con A) is a type of legume lectin 
that binds specifically to terminal Į-D-mannosyl and Į-D-glucosyl 
groups present on the surface of all bacteria.29,30 In addition, our 
group has previously reported its use with silver nanoparticles as 
a molecular imaging agent, investigating carbohydrate-lectin in-
teractions occurring at the surface of mammalian cells using 
SERS.31 Furthermore, we have prior knowledge of combining 
functionalised silver nanoparticles with silver-coated magnetic 
nanoparticles in a stable sandwich-type assay for SERS detection 
of DNA.32 Hence, by exploiting our previous knowledge and the 
fact that lectins bind specifically to sugar moieties on the surface 
of bacteria, we have in the present study developed a sensitive 
bionanosensor which is capable of isolating and detecting multi-
ple bacterial pathogens simultaneously. We believe our SERS bi-
onanosensor can provide all the requirements (sensitivity, repro-
ducibility, cost, ease of use and speed of analysis) which are re-
quired for a point of care assay and offer opportunities for future 
advancements in healthcare applications. 
Experimental 
Silver nanoparticles and silver coated magnetic nanoparticles 
were synthesised using methods previously reported by Lee et al. 
and Kumar et al.33,34 The colloidal solutions had an average par-
ticle size of 80.9 nm and 253.3 nm respectively. The biomolecule-
nanoparticle conjugates which were used in these studies were 
prepared using modified methods previously described by Simp-
son et al. and Donnelly et al.17,32 Detailed protocols for the prep-
aration and characterisation of these colloidal suspensions are 
provided in the experimental section of the ESI. 
Bacterial Strains  
Bacterial Strains: Escherichia coli ATCC 25922; Staphylococcus au-
reus (methicillin resistant) ATCC BAA-1766 and Salmonella typhi-
murium ATCC 14028 were used in this study.  The growth con-
ditions and protocol detailing the preparation of the bacterial 
slurries are provided in the ESI.  
Detection Assay 
Single pathogen detection: For each of the 3 bacterial pathogens 
the following procedure was carried out - SERS active antibody 
functionalised silver nanoparticles (200 µL; Ab-AgNP) were 
added together with lectin functionalised silver coated magnetic 
nanoparticles (200 µL; Con A-Ag@MNP) and a specific bacterial 
strain (50 µL, 104 CFU/mL). Note for the control sample, the 
bacteria was replaced with d.H2O (50 ȝL) only. The sample was 
mixed thoroughly for 30 min before being placed in a magnetic 
rack for a further 30 min to allow the sample to collect. The clear 
supernatant was removed and the sample re-suspended in d.H2O 
(450 ȝL) ready for analysis. The same procedure was followed for 
the concentration studies except the bacteria concentration was 
varied from 104 to 101 CFU/mL. To confirm concentration de-
pendence, an extended concentration study was conducted for 
E. coli bacteria only where the assay was performed over the range 
107 to 101 CFU/mL. It should be noted that each sample was 
prepared in triplicate. 
Multiple pathogen detection: The three sets of antibody function-
alised silver nanoparticles (100 µL of each conjugate) were added 
together with lectin functionalised silver coated magnetic nano-
particles (200 µL) plus the three bacterial strains (50 µL of each 
pathogen; 103 CFU/mL). Note for the control sample, the bac-
teria was replaced with d.H2O (150 ȝL) only. The same proce-
dure as described above (for the single pathogen detection) was 
employed, except the sample was re-suspended in 650 µL of 
d.H2O.  
SERS and Multivariate Analysis 
Raman reporters used were malachite green isothiocyanate 
(MGITC); 7-dimethylamino-4-methylcoumarin-3-isothiocyanate 
(DACITC) and 4-(1H-pyrazol-4-yl)-pyridine (PPY) and these were 
used to detect E. coli, S. typh and MRSA respectively.  
The samples were analysed immediately after preparation us-
ing a Renishaw InVia Raman microscope. Specifically, the Ra-
man spectra were acquired using a 532 nm laser excitation with 
a 20x long working distance objective lens focused into a 96 well 
plate containing 300 µL of the bacteria-NP conjugate solution. 
The laser power was adjusted each time to ~0.8 mW and an ac-
quisition time of 1 s with a static scan being centred at 1300 cm -
1 was employed. For all Raman spectra, data handling was carried 
out using GRAMS/AI software. The peak intensities were ob-
tained by scanning 3 replicate samples 5 times and in all plots 
the error bars represent one standard deviation. 
All multivariate statistical analysis was carried out in MATLAB 
software (The MathWorks, Natick, USA). Prior to conducting 
principal component analysis (PCA) the data was baseline cor-
rected using asymmetric least-squares (AsLS).35 PCA was per-
formed on four different data sets, three consisting of spectra ob-
tained from single pathogen detection experiments
 and one data set obtained for the multiplex detection of the 
three pathogens.36  
Results and Discussion 
Characterisation of Biomolecule-NP Conjugates 
The developed bionansosensor is based on a sandwich type 
SERS assay with the detection strategy provided in Figure 1. 
Initially, maghemite (Ȗ-Fe2O3) magnetic nanoparticles were syn-
thesised using a co-precipitation method, and then coated with 
a silver shell via a glucose reduction protocol previously de-
scribed by Donnelly et al.32 The silver coated magnetic nanopar-
ticles were functionalised with a heterobifunctional thiol/car-
boxy PEGylated linker and the legume lectin, Concanvilin A 
(Con A), via carbodiimide cross-coupling chemistry.17,32,37 Con-
jugating Con A to the surface of silver coated magnetic nano-
particles, in the presence of a magnet allowed for us to develop 
a unique and efficient way of capturing bacteria from a sample 
matrix.  
Con A functionalised magnetic nanoparticles were prepared 
using modified methods previously described by Simpson et al. 
and Donnelly et al.17,32 The magnetic nanoparticle conjugates 
were optimised and characterised using extinction spectros-
copy, dynamic light scattering and zeta potential analysis. The 
data obtained at each stage of the conjugation process (Figure 
S1) along with a detailed discussion of the results are provided 
in the ESI. In summary, a shift from 420 to 430 nm in the 
localised surface plasmon resonance (LSPR) plus broadening of 
the peak was observed after the addition of the Con A lectin 
(Figure S1 (a)). Furthermore, an increase in size and decrease 
in zeta potential (Figure S1 (c) and (d) respectively) were ob-
served at each stage of the conjugation indicating that there was 
a change to the surface environment of the nanoparticle and 
thus confirming the successful attachment of both the 
PEGylated linker and the Con A lectin to the magnetic nano-
particles. 
It was also important to optimise and characterise each step 
of the conjugation process for the SERS active antibody func-
tionalised silver nanoparticles. Silver nanoparticles were ini-
tially synthesised using a modified Lee and Miesel method.33 
Following this the SERS active conjugates were prepared by 
functionalising the silver nanoparticles with a Raman reporter, 
PEGylated linker and antibodies that were bacterial strain spe-
cific. Again, carbodiimide cross-linking chemistry was used to 
immobilise the antibodies onto the nanoparticle surface and 
the conjugates characterised using the same techniques as those 
previously employed for the Con A functionalised magnetic na-
noparticles. It should be noted that the three sets of antibody 
conjugates (E. coli, S. typh and MRSA) were optimised and char-
acterised in the same way, with similar trends being observed 
in the data sets hence, only the data associated with the E. coli 
antibody is shown in Figure S1 (ESI). A detailed discussion of 
the characterisation of the SERS active conjugates is provided 
in the ESI. Briefly, a LSPR shift from 407 to 413 nm plus 
broadening and dampening of the peak was observed upon 
conjugating with the E. coli antibody. In addition, a size in-
crease and decrease in zeta potential (Figure S1 (c and d)) were 
observed at each stage of the conjugation confirming the suc-
cessful attachment of the bio-molecule. Moreover, the SERS re-
sults showed that with a 1 s accumulation time and 532 nm 
laser an excellent signal could be obtained from the SERS ac-
tive conjugates (Figure S1 (e)). For further clarification on the 
successful conjugation and to confirm the stability of the col-
loidal solutions, gel electrophoresis was performed (Figure S1 
(f)). These results along with those observed for the Con A func-
tionalised magnetic nanoparticles suggested that the function-
alisation conditions were optimal for use in the next stage of 
the studies which was developing the assay for single pathogen 
detection.17  
Detection Assay 
The detection assay is based on a sandwich-type SERS ap-
proach, involving the use of Con A functionalised magnetic 
nanoparticles and SERS active nanoparticles functionalised 
with antibodies that are bacterial strain specific. It is important 
to note that the Raman reporter (highlighted as stars in the 
schematic in Figure 1) is only present on the bio-recognition 
nanoparticles and not on the magnetic nanoparticles. Hence, a 
SERS signal is only observed when the SERS active nanoparti-
cle binds specifically to its bacterial target. As shown in Figure 
1 (a-c), a SERS signal is only obtained (green spectrum) when 
both the bio-recognition nanoparticles and the magnetic nano-
particles bind to the bacterial target. A magnet is then applied 
and magnetic separation is used to remove the SERS active 
complex from the matrix volume. In the case where there was 
no bacterial target present (control sample; red spectrum), the 
SERS active nanoparticles remain in the bulk solution and are 
washed away, leaving only the magnetic nanoparticles captured 
and bound to the magnet. These nanoparticles are non-Raman 
active, and hence only produce weak background signals. Fol-
lowing the separation step, the SERS active complex and con-
trol samples are re-suspended in d.H2O and analysed using a 
532 nm laser. In terms of the multiplexing step (Figure 1d) the 
procedure described above was followed, except that three sep-
arate sets of bio-recognition nanoparticles were prepared each 
specific for one strain of bacteria only and each with a unique 
Raman reporter. The Raman reporter produces a molecularly 
specific spectrum and each reporter contains a characteristic 
peak which can be used to identify and easily discriminate be-
tween the individual components in a sample mixture.38 It can 
be seen in the SERS spectra of Figure 1d, that 3 characteristic 
peaks have been highlighted (*), each one is unique to a Raman 
reporter and hence is used to identify which bacterial target is 
present. 
Figure 2 shows the results for each of the three bacterial path-
ogen tests conducted. Figure 2 (a-c) provides the results for E. 
coli, (d-f) S. typh and (g-i) the results of the MRSA, all of these 
are single-plex assays. It can be seen in Figure 2 (a) that when 
both the SERS active biorecognition conjugates and the mag-
netic conjugates bind to the E. coli bacteria and are pulled from 
the matrix volume using a magnet, that successful identifica-
tion of each of the bacteria can be made due to a large SERS 
signal (green spectrum) being observed. The Raman spectrum 
is due to the Raman reporter malachite green isothiocyanate 
(MGITC; chemical structure given in Figure 2 (c)) which was 
added to the E. coli biorecognition conjugates; therefore it al-
lowed us to confidently confirm the presence of the E. coli bac-
teria. In terms of the control sample, when no bacteria were 
added to the matrix volume, it can be seen that only a very weak 
SERS signal was observed (red spectrum). This weak signal is 
 due to residual SERS active biorecognition conjugates not be-
ing completely washed away during the separation step. How-
ever, this signal is negligible as it is clear there is a large en-
hancement in the signal observed from the SERS active bacte-
ria complex over the control.  
The enhancement in SERS signal from the sample over the 
control is due to the unique design of this assay. Firstly, the use 
of Con A functionalised magnetic nanoparticles, allows for 
multi-valent interactions to take place between the lectin and 
the sugar moieties on the bacteria surface.30 In addition to this, 
the magnetic core of the nanoparticles enables the use of a mag-
net in which magnetic separation can be employed to capture 
and isolate the bacteria-nanoparticle complex from the matrix 
volume. This allows for sample concentration and any un-
bound material to be washed away, ultimately reducing the 
background signal and the chance of false positives. Secondly, 
the surface of bacteria also provides multiple binding sites for 
interacting with antibody functionalised nanoparticles.1 The bi-
orecognition event, which occurs between SERS active anti-
body functionalised nanoparticles and antigens present on the 
surface of bacteria, results in enhanced SERS signals being ob-
tained (as seen in Figure 2 (a)). The multi-valent interaction 
which occurs enables the nanoparticles to come in-close prox-
imity to one another, resulting in areas of highly localised elec-
tromagnetic fields known as SERS hot-spots and these give rise 
to increased Raman signals.39 Therefore, it can be confirmed 
that the enhancement in SERS signal for the sample over the 
control was due to the SERS active nanoparticles binding spe-
cifically to the bacterial target; with the help of the lectin func-
tionalised magnetic nanoparticles capturing and isolating the 
bacteria complex from the sample matrix. Thus, the signal en-
hancement was a result of both conjugates being present and 
binding to the E. coli bacteria.  
When no bacteria were present however, the SERS active bi-
orecognition nanoparticles were unable to bind and therefore 
could not be pulled down by the magnet during the separation 
step. Essentially they were washed away with the remaining un-
bound matrix volume, leaving only the magnetic nanoparticles 
to be analysed, thus resulting in a very weak Raman signal being 
obtained. It is evident from Figure 2 (a) and further clarified in 
Figure 2 (b) that a signal enhancement of ~10 times is observed 
for the E. coli bacteria sample over the control. The characteris-
tic peak at 1616 cm-1 which arises due to aromatic ring stretch-
ing within the MGITC molecule,40 was used to calculate the 
peak intensity values. Peak intensities were obtained by scan-
ning 3 replicate samples 5 times and the error bars represent 
one standard deviation. The total analysis time was ~1 h from 
mixing the sample to obtaining the SERS results. Therefore, in 
comparison to culture based methods where it can take up to 
7 days for results to be obtained, a bionanosensor capable of 
rapidly isolating and simultaneously detecting E. coli bacteria 
has been demonstrated. We believe however, that this analysis 
time could be further improved with additional optimisation 
and automation of the wash steps. 
The number of bacterial pathogens which could be detected 
was extended to S. typh, another Gram-negative bacterial strain, 
and MRSA, a Gram-positive bacterial strain, which were cho-
sen to show the breadth and facile adaptability of the biona-
nosensor. The results of the single pathogen tests for S. typh and 
MRSA can be observed in Figure 2 (d-f) and (g-i) respectively. 
The Raman reporter DACITC (dimethylamino-4-methyl-
coumarin-3-isothiocyanate) with a characteristic peak at 535 
cm-1 was used to detect S. typh, whilst PPY (4-(1H-pyrazol-4-yl)-
pyridine) with a characteristic peak at 955 cm-1 was used to de-
tect the presence of MRSA. Similar results were observed for 
these two bacterial strains as those previously seen with the E. 
coli bacteria, such that intense SERS signals were obtained 
when the bacteria was present and very weak signals when they 
were not. In terms of the S. typh bacteria, a signal enhancement 
of ~13 times (blue spectrum) was observed for the SERS active 
bacteria complex over the control sample (red spectrum). 
Whilst the signal for the MRSA bacteria complex (orange spec-
trum) over the control sample was ~11 times greater, thus fur-
ther demonstrating the level of discrimination which can be 
achieved using this approach. Moreover, we have demonstrated 
that this bionanosensor is both speedy and versatile as it is ca-
pable of isolating and detecting both Gram-positive and Gram-
negative bacterial pathogens. Further, the discrimination 
which can be achieved between sample and control is undeni-
able. 
Single Pathogen Detection  
For this approach to represent an advancement over current 
methodologies, it also has to be sensitive as well as fast. There-
fore, concentration studies for each of the 3 bacterial pathogens 
were conducted to determine what the cell concentration limit 
would be, in terms of discriminating between the SERS active 
bacteria complex and the control. The assay was performed for 
each of the pathogens over the bacteria concentration range 104 
to 101 CFU/mL. Figure 3, shows the SERS spectra obtained at 
each of the concentrations plus a control spectrum for compar-
ison, for (a) E. coli, (b) S. typh and c) MRSA.  Additionally, asso-
ciated bar charts detailing the SERS peak intensities for each 
of the bacteria concentrations are also provided. For ease and 
visual clarification each of the bar chart contains a dashed line, 
this is used to highlight the peak intensity of the control. Fur-
thermore, an extended concentration study was conducted for 
E. coli bacteria where the assay was performed over the range 
107 to 101 CFU/mL. The results from this can be seen in Figure 
S2 (ESI) but it was obvious that at bacteria concentrations 
greater than 104 CFU/mL, too many bacteria were present in 
the sample causing the binding of large numbers of nanoparti-
cles followed by concentration into a small volume by magnetic 
capture. This resulted in dampening of the SERS signal due to 
self-absorbance of the Raman scattered light. There was a clear 
concentration dependence at 104 CFU/mL and below, and as 
such the sensitivity was only conducted from 104 to 101 
CFU/mL. As previously mentioned, the concentration studies 
produced similar results with the greatest SERS signals being 
obtained when cell concentrations of 104 CFU/mL were em-
ployed. The weakest SERS responses were observed from the 
controls therefore, even at low bacteria concentrations of 101 
CFU/mL, using this approach we were able to discriminate be-
tween the SERS active bacteria complexes and the controls. 
,QWHUPVRIWKHDVVD\¶VVHQVLWLYLW\LWLVREYLRXVIURP)LJXUH
that detection can confidently be made with cell concentra-
tions between 104 and 102 CFU/mL for all three bacterial path-
ogens. The signals for the SERS active bacteria complexes at 
these concentrations are far superior to the controls. The low-
est discrimination between the sample and control however, 
was found to be with a bacteria concentration of 101 CFU/mL. 
 For the E. coli bacteria, the SERS active bacteria complex pro-
duced a SERS signal twice that of the control, confirming that 
we were able to discriminate between the two samples and thus 
able to detect E. coli bacteria at a concentration of 101 
CFU/mL. Additionally, it was possible to detect S. typh and 
MRSA at this concentration also, with signal enhancements of 
~1.5 and 1.7 being observed for the SERS active bacteria com-
plexes over the control samples respectively. It should be noted 
however, 50 uL of bacteria was used in these assays hence the 
detection limit is actually lower than 101 CFU/ml, as the num-
ber of bacteria present in these samples is less than if 1 mL of 
bacteria had been added. Moreover, we have successfully 
demonstrated that this SERS bionanosensor is not only rapid 
and versatile but also sensitive in detecting bacterial pathogens. 
In addition, the bionanosensor is capable of detecting concen-
trations which are clinically relevant, with current methodolo-
gies typically detecting 103 CFU/mL.41,42 
Multiple Pathogen Detection  
Food contamination is a threat to public health and it can 
occur at any stage between preparation and consumption; af-
fecting 500,000 people in the UK alone each year. Our biona-
nosensor is capable of detecting multiple bacterial pathogens 
simultaneously and in the case of food pathogens where co-in-
fection is plausible we demonstrate the successful detection of 
both E. coli and S. typh simultaneously (Figure S3). However to 
demonstrate the diversity and adaptability of this bionanosen-
sor we have chosen to detect food pathogens and MRSA which 
also has a huge impact on human health. For the multiplex de-
tection assay, the same procedure described previously was fol-
lowed except three separate sets of bio-recognition nanoparti-
cles were prepared each specific for one strain of bacteria only 
and each with a unique Raman reporter. Figure 4 (a) shows the 
SERS spectrum obtained when all three bacterial pathogens (E. 
coli, S. typh and MRSA) were present in the sample. This multi-
plex spectrum (black) was compared to the SERS spectra ob-
tained when each of the pathogens were detected individually 
and a control sample for when no bacteria was present (red).  
The DACITC spectrum (blue) represents S. typh; MGITC 
spectrum (green) represents E. coli; PPY spectrum (orange) rep-
resents MRSA. It can be seen in Figure 4 (a) that the black dot-
ted line highlights three peaks at 535, 955 and 1445 cm-1 which 
are unique to each of the Raman reporters (DACITC, PPY and 
MGITC) and hence used to identify the presence of each of the 
bacterial targets (S. typh, MRSA and E. coli) respectively. The 
peak at 1616 cm-1 used previously to detect E. coli, occurs close 
to a peak in the MRSA (PPY peak at 1610 cm-1) spectrum, there-
fore to confirm the presence of E. coli the peak at 1445 cm-1 was 
chosen instead. TKLVELRQDQRVHQVRUSURYLGHVDµRQHSRW¶GHWHF
tion system for multiple bacterial pathogens but more im-
portant than that, it is capable of isolating and discriminating 
between the bacterial strains being analysed. As the multiplex 
spectrum is multivariate in nature, it is not always reliable to 
analyse the spectrum by eye alone, thus multivariate analysis in 
the form of principal component analysis (PCA) was performed 
on the multiplex spectrum along with the three single pathogen 
spectra. Figure 4 (b) shows the PCA scores plot showing the 
relationship between the multiplex spectra and each of the 
three single pathogen spectra. PCA is a common method for 
the analysis of spectroscopic data,7,36 and the resulting principal 
component (PC) scores plot (Figure 4 (b)) clearly illustrates how 
strong the relationship was between the multiplex spectra and 
the pathogen spectra with four unique groupings being identi-
fied. It can be seen that the single bacterial pathogen samples 
form the edges of a triangle with the triplex sample clustering 
in the middle. The black crosses represent the triplex spectra; 
green circles are E. coli; blue squares are S. typh and red dia-
monds are MRSA. Five scans of 3 replicate samples are shown 
in the PCA plot and each group is tightly clustered illustrating 
the excellent reproducibility of the SERS spectra and hence the 
whole analytical approach including bacterial isolation as well 
as detection. The SERS spectra from the triplex sample are also 
clustered tightly together and are clearly separated from the sin-
gle bacterial samples. Thus, the PCA supports the previous 
findings in which successful identification and discrimination 
between the bacterial pathogens in the multiplex can be made. 
Moreover, it is not only important to be able to discriminate 
between the bacterial pathogens within the multiplex but it is 
vital that the bionanosensor is capable of discriminating be-
tween the SERS active bacteria complex and the control sample 
(when no bacteria are added).  
The difference in signal intensity between the triplex sample 
and control is clearly observed in Figure 4 (a), however for fur-
ther clarification, Figure 4 (c) provides the associated peak in-
tensity values with error bars for the 1616 cm-1 peak. It can be 
seen that when the bacterial targets were present, an intense 
SERS spectrum was obtained (black spectrum) and as explained 
previously this was due to a biorecognition interaction occur-
ring between the nanoparticle conjugates and the three bacte-
rial strains. However, when no bacteria were present, then only 
a weak Raman signal was observed (red spectrum). The SERS 
signal for the triplex sample was ~6 times greater than that ob-
served for the control, demonstrating the effectiveness of this 
approach. Again, the total analysis time was ~1 h. This is com-
parable with other bionanosensors which have been developed 
but where this approach is unprecedented is that it can detect 
multiple pathogens simultaneously in this time, whereas previ-
ous methods are for single pathogen detection only.2,3 Further-
more, this bionanosensor is easy to use and can be adapted for 
use with portable Raman instruments, making it ideal for use 
with point of care devices. The sensitivity which can be 
achieved by this bionanosensor is also below the recommended 
OLPLWVFXUUHQWO\ UHTXLUHG IRUFOLQLFDOGLDJQRVLV ZKLFK LV3 
CFU/mL).41,42 Therefore; it offers significant advancements 
over existing methods and offers the opportunity for advance-
ments in healthcare applications.   
Conclusions 
A SERS bionanosensor which is rapid, sensitive and capable 
of isolating and detecting multiple bacterial pathogens simulta-
neously has been demonstrated. This novel approach involves 
combining a sandwich type assay with magnetic separation in 
which a magnet is used to capture a SERS active bacteria com-
plex and isolate it from a matrix volume. Using this detection 
assay, cell concentrations as low as 101 CFU/mL were readily 
detected in single pathogen tests for E. coli, S. typh and MRSA. 
Furthermore, 3 bacterial strains were isolated and detected sim-
ultaneously in a multiplex system, with discrimination being 
made using both PCA and SERS analysis. The sensitivity of this 
 bionanosensor has been demonstrated with bacterial concen-
trations below the requirements for clinical diagnosis being 
made. This multiplexed bionanosensor is capable of providing 
fast and sensitive discrimination of bacterial pathogens both 
individually and within a multiplex system offering opportuni-
ties for future advancements in clinical diagnosis and bio-med-
ical applications.  
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Figure 1. Schematic illustrating the single-plex and multiplex detection assay. Assay format: a) lectin (Con A) functionalised silver coated 
magnetic nanoparticles (Ag@MNPs) will bind to bacteria and the presence of the magnet will allow for magnetic separation of the bacteria 
from the sample matrix b) SERS active silver nanoparticles (AgNPs) functionalised with a biorecognition molecule (antibody; Ab) and a 
unique SERS reporter are added. The mixture is shaken for 30 min before applying a magnet for a further 30 min and allowing the sample 
to collect. Any unbound matrix is gently removed and the sample subsequently re-suspended in d.H2O c) The sample is then interrogated 
with a 532 nm laser beam and SERS signal obtained (green spectrum). When no target is present the functionalised AgNPs will be washed 
away, thus they will not bind to bacteria so a minimum SERS signal obtained (red spectrum). d) Multiplexing step: 3x AgNP conjugates 
each functionalised with a different Raman reporter and an antibody (which is specific for a bacterial pathogen) are added together with 3 
bacterial pathogens and Con A (which binds to all three bacteria) functionalised Ag@MNPs. In the same way as the single-plex systems 
magnetic separation allows for the samples to be concentrated and analysed via a 532 nm laser. A SERS spectrum is obtained which contains 
characteristic peaks from the three Raman reporters and thus can be used to confirm the targets are present. 
 
Figure 2. SERS spectra obtained from single pathogen detection using the SERS assay. a) SERS spectrum of MGITC observed when de-
tecting E. coli (green) and the control spectrum representing when no bacteria was present (red); b) SERS peak intensities at 1616 cm-1 for 
assay and control when detecting E. coli; c) Chemical structure for the Raman reporter, MGITC; d) SERS spectrum of DACITC observed 
when detecting S. typh (blue) and the control spectrum (red); e) SERS peak intensities at 535 cm-1 for assay and control when detecting S. 
typh; f) Chemical structure for DACITC; g) SERS spectrum of PPY observed when detecting MRSA (orange) and the control spectrum 
(red); h) SERS peak intensities at 955 cm-1 for assay and control when detecting MRSA; i) Chemical structure for PPY. The bacteria con-
centration used was 104 CFU/mL. SERS spectra were recorded using a 532 nm laser excitation with an accumulation time of 1s. Peak 
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intensities were obtained by scanning 3 replicate samples 5 times and the error bars represent one standard deviation. The (*) highlights a 
characteristic peak which is used to identify the Raman reporter hence the bacterial pathogen present but it also used to calculate the peak 
intensities throughout. 
 
Figure 3. The assay was performed for each of the pathogens over the bacteria concentration range 104 to 101 CFU/mL. Comparison SERS 
spectra showing changes in signal for a) MGITC detecting E. coli, b) DACITC detecting S. typh and c) PPY detecting MRSA. The associated 
bar charts show the SERS peak intensities at each of the bacteria concentrations and these are compared to a control sample (no bacteria 
present). The characteristic peaks 1616, 535 and 955 cm-1 were used to calculate the peak intensities for E. coli, S. typh and MRSA respec-
tively. SERS spectra were recorded using a 532 nm laser excitation with an accumulation time of 1s. Peak intensities were obtained by 
scanning 3 replicate samples 5 times and the error bars represent one standard deviation. The dashed line gives visual clarification of the 
SERS peak intensity of the control. 
 
Figure 4. SERS spectra obtained from multiple pathogen detection using the SERS assay. a) Stacked SERS spectra showing the raw spectra 
obtained from the detection of all three bacterial pathogens simultaneously using the detection assay and a control sample for comparison 
when no bacteria was present plus the SERS spectra obtained from the detection of each pathogen separately. Control spectrum is red, 
DACITC spectrum (blue) represents S. typh; MGITC spectrum (green) represents E. coli; PPY spectrum (orange) represents MRSA and the 
black spectrum is the multiplex containing all three bacterial pathogens. The black dotted lines show peaks that are unique to each Raman 
reporter and hence used to identify the presence of the bacterial targets. The bacteria concentration used was 103 CFU/mL. b) PCA scores 
plot showing the relationship between the multiplex spectra and each of the three single pathogen spectra. The black crosses represent the 
triplex spectra; green circles are E. coli; blue squares are S. typh and red diamonds are MRSA. c) Comparative peak intensities at 1616 cm-1 
for assay and control. SERS spectra were recorded using a 532 nm laser excitation with an accumulation time of 1s. Peak intensities were 
obtained by scanning 3 replicate samples 5 times and the error bars represent one standard deviation. TEV = total explained variance. 
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